|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Katholieke Universiteit Leuven Fund for Scientific Research, Flanders, Belgium IWT, Flanders, Belgium |
|---|---|
| Information provided by: | Katholieke Universiteit Leuven |
| ClinicalTrials.gov Identifier: | NCT00495924 |
Purpose
The purpose of this study is to determine whether early recurrence after curative resection of ductal pancreatic adenocarcinoma can be explained by either dissemination of cancer cells during intraoperative tumour manipulation, post-operative systemic immune suppression, alteration of biological properties of circulating cancer cells or a combination of these.
| Condition | Intervention |
|---|---|
|
Pancreatic Neoplasms Adenocarcinoma Neoplasm Circulating Cells Tumor Markers, Biological Monitoring, Immunologic |
Procedure: Pancreatic resection (PD) |
| Study Type: | Observational |
| Study Design: | Prospective |
| Official Title: | Prognostic Relevance of Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma |
| Estimated Enrollment: | 100 |
| Study Start Date: | October 2006 |
| Estimated Study Completion Date: | October 2008 |
Show Detailed Description Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Baki Topal, MD, PhD | 0032(0)16343149 | baki.topal@uz.kuleuven.ac.be |
| Contact: Gregory Sergeant, MD | 0032(0)1644377 | gregory.sergeant@uz.kuleuven.ac.be |
| Belgium, Vlaams-Brabant | |
| Department of Abdominal Surgery, Catholic University Leuven | Recruiting |
| Leuven, Vlaams-Brabant, Belgium, B-3060 | |
| Contact: Baki Topal, MD, PhD 0032(0)16343149 baki.topal@uz.kuleuven.ac.be | |
| Contact: Gregory Sergeant, MD 0032(0)16344377 gregory.sergeant@uz.kuleuven.ac.be | |
| Study Director: | Baki Topal, MD, PhD | Catholic University Leuven, Belgium |
| Principal Investigator: | Gregory Sergeant, MD | Catholic University Leuven |
More Information
| Study ID Numbers: | 3M070038, G.0635.07 |
| Study First Received: | July 2, 2007 |
| Last Updated: | November 25, 2008 |
| ClinicalTrials.gov Identifier: | NCT00495924 |
| Health Authority: | Belgium: Ministry of Social Affairs, Public Health and the Environment |
|
Digestive System Neoplasms Pancreatic Neoplasms Endocrine System Diseases Carcinoma Digestive System Diseases Neoplasm Metastasis Gastrointestinal Neoplasms |
Pancreatic Diseases Endocrinopathy Adenocarcinoma Neoplasm Circulating Cells Neoplasms, Glandular and Epithelial Endocrine Gland Neoplasms |
|
Neoplastic Processes Neoplasms Neoplasms by Site Pathologic Processes Neoplasms by Histologic Type |
